These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18842900)

  • 1. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801.
    Errico F; Rossi S; Napolitano F; Catuogno V; Topo E; Fisone G; D'Aniello A; Centonze D; Usiello A
    J Neurosci; 2008 Oct; 28(41):10404-14. PubMed ID: 18842900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the role of free D-aspartate in the mammalian brain.
    Errico F; Napolitano F; Nisticò R; Usiello A
    Amino Acids; 2012 Nov; 43(5):1861-71. PubMed ID: 22851050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia.
    Errico F; Mothet JP; Usiello A
    J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-aspartate: an atypical amino acid with neuromodulatory activity in mammals.
    Errico F; Napolitano F; Nisticò R; Centonze D; Usiello A
    Rev Neurosci; 2009; 20(5-6):429-40. PubMed ID: 20397623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
    Pei JC; Hung WL; Lin BX; Shih MH; Lu LY; Luo DZ; Tai HC; Studer V; Min MY; Lai WS
    J Psychopharmacol; 2019 Oct; 33(10):1288-1302. PubMed ID: 31294644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.
    Tsai G; Ralph-Williams RJ; Martina M; Bergeron R; Berger-Sweeney J; Dunham KS; Jiang Z; Caine SB; Coyle JT
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8485-90. PubMed ID: 15159536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
    Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhythmic theta and delta activity of cortical and hippocampal neuronal networks in genetically or pharmacologically induced N-methyl-D-aspartate receptor hypofunction under urethane anesthesia.
    Kiss T; Feng J; Hoffmann WE; Shaffer CL; Hajós M
    Neuroscience; 2013 May; 237():255-67. PubMed ID: 23396086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA(A) alpha 1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment.
    Reynolds DS; O'Meara GF; Newman RJ; Bromidge FA; Atack JR; Whiting PJ; Rosahl TW; Dawson GR
    Neuropharmacology; 2003 Feb; 44(2):190-8. PubMed ID: 12623217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
    de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
    Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia.
    Kraeuter AK; van den Buuse M; Sarnyai Z
    Schizophr Res; 2019 Apr; 206():244-250. PubMed ID: 30466960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning.
    Kawabe K; Iwasaki T; Ichitani Y
    Brain Res; 2007 Sep; 1169():77-86. PubMed ID: 17706184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free d-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking d-aspartate oxidase activity.
    Nuzzo T; Feligioni M; Cristino L; Pagano I; Marcelli S; Iannuzzi F; Imperatore R; D'Angelo L; Petrella C; Carella M; Pollegioni L; Sacchi S; Punzo D; De Girolamo P; Errico F; Canu N; Usiello A
    Exp Neurol; 2019 Jul; 317():51-65. PubMed ID: 30822420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA glutamate receptor role in the development of context-dependent and independent sensitization of the induction of stereotypy by amphetamine or apomorphine.
    Battisti JJ; Uretsky NJ; Wallace LJ
    Behav Brain Res; 2000 Sep; 114(1-2):167-74. PubMed ID: 10996057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.
    Hashimoto K; Fujita Y; Horio M; Kunitachi S; Iyo M; Ferraris D; Tsukamoto T
    Biol Psychiatry; 2009 Jun; 65(12):1103-6. PubMed ID: 19217074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.